Literature DB >> 29941295

Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis.

Courtney L M Nelson1, Hayley M Amsbaugh1, James L Reilly2, Cherise Rosen3, Robert W Marvin3, Michael E Ragozzino4, Jeffrey R Bishop5, John A Sweeney6, S Kristian Hill7.   

Abstract

This study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antipsychotic; COMT; PCET; Psychosis

Mesh:

Substances:

Year:  2018        PMID: 29941295     DOI: 10.1016/j.schres.2018.06.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

1.  Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives.

Authors:  William C Hochberger; Courtney L M Eskridge; Jeffrey R Bishop; James L Reilly; Leah H Rubin; Sarah Keedy; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Michael Ragozzino; Matcheri S Keshavan; John A Sweeney; S Kristian Hill
Journal:  Schizophr Res       Date:  2020-08-21       Impact factor: 4.939

2.  Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia.

Authors:  Ahmed Naguy; Abdul-Mohsen Al-Humoud; Saxby Pridmore; Mohamed Y Abuzeid; Anubhuti Singh; Dalal Elsori
Journal:  Psychopharmacol Bull       Date:  2022-02-25

Review 3.  Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review.

Authors:  Diane Merino; Arnaud Fernandez; Alexandre O Gérard; Nouha Ben Othman; Fanny Rocher; Florence Askenazy; Céline Verstuyft; Milou-Daniel Drici; Susanne Thümmler
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.